![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
Pharmalink AB Archimedes Development Ltd |
---|---|
Information provided by: | Pharmalink AB |
ClinicalTrials.gov Identifier: | NCT00767221 |
The study will investigate the effect of PL-56 on albumin leakage and renal function (glomerular filtration rate) in patients with IgA nephropathy. It will also assess the safety of treatment with PL-56.
Condition | Intervention | Phase |
---|---|---|
IGA Nephropathy |
Drug: Budesonide |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study |
Estimated Enrollment: | 20 |
Study Start Date: | October 2005 |
Study Completion Date: | November 2008 |
Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental
The patient is his own control. Endpoint variables are measured before, during and after treatment.
|
Drug: Budesonide
8 mg PL-56 once daily for six months
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Sweden | |
Huddinge University Hospital | |
Stockholm, Sweden | |
Linköping University Hospital | |
Linköping, Sweden | |
Uppsala University Hospital | |
Uppsala, Sweden |
Principal Investigator: | Bengt Fellström, MD, PhD | Uppsala University Hospital, Dept. of Medicine |
Responsible Party: | Pharmalink AB ( Johan Häggblad ) |
Study ID Numbers: | U-03-003 |
Study First Received: | October 5, 2008 |
Last Updated: | April 20, 2009 |
ClinicalTrials.gov Identifier: | NCT00767221 History of Changes |
Health Authority: | Sweden: Medical Products Agency |
Anti-Inflammatory Agents Glomerulonephritis Autoimmune Diseases Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Budesonide Anti-Asthmatic Agents Hormones |
Glucocorticoids Urologic Diseases Nephritis Glomerulonephritis, IGA Kidney Diseases Peripheral Nervous System Agents Bronchodilator Agents Berger Disease |
Anti-Inflammatory Agents Respiratory System Agents Glomerulonephritis Autoimmune Diseases Immune System Diseases Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Budesonide Anti-Asthmatic Agents Hormones |
Glucocorticoids Pharmacologic Actions Urologic Diseases Autonomic Agents Nephritis Therapeutic Uses Glomerulonephritis, IGA Peripheral Nervous System Agents Kidney Diseases Bronchodilator Agents |